logo
What is the Nordic Protocol, Magda Szubanski's cancer treatment?

What is the Nordic Protocol, Magda Szubanski's cancer treatment?

The Age5 days ago

On Thursday, beloved Australian actress Magda Szubanski announced that she has stage four cancer.
The 64-year-old, known for her performances in Kath and Kim and sketch show Fast Forward, also revealed she was starting 'one of the best treatments available' – the Nordic protocol.
Here's what we know about it.
What is the Nordic Protocol?
The Nordic Protocol is a type of chemoimmunotherapy treatment. It combines chemotherapy (which slows the growth of cancer cells) with immunotherapy (which aims to restore the immune system).
According to the NSW Cancer Institute, the treatment is suitable for patients under 65 with previously untreated mantle cell lymphoma. Also known as the Nordic Regimen, its name comes from a major trial that happened at the Danish-based Nordic Lymphoma Group.
What is mantle cell lymphoma?
Mantle cell lymphoma is a rare type of B cell non-Hodgkin lymphoma. It is a cancer of the lymphatic system – part of the immune system which produces immune cells and protects the body from viruses and bacteria.
According to the Leukaemia Foundation, the cancer is relatively uncommon, accounting for between 5 per cent and 10 per cent of non-Hodgkin lymphomas.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Son's intuition reveals Aussie Olympic gold medallist's pregnancy
Son's intuition reveals Aussie Olympic gold medallist's pregnancy

Perth Now

time2 hours ago

  • Perth Now

Son's intuition reveals Aussie Olympic gold medallist's pregnancy

Australian Winter Olympic gold medallist Torah Bright has announced she is pregnant with her third child. The 38-year-old former snowboarder has two sons with husband Angus Thomson — and she says it was their eldest who first revealed the latest addition. Bright said they are 'so excited' to become a family of five. 'The boys are hyped and so sweet with their baby growing in my belly!' she wrote. On Wednesday, Bright said they are not learning the gender until the baby arrives. 'But I'm feeling a third boy,' she said. The dual Olympic halfpipe medallist also shared that son Flow 'knew I was pregnant before I actually was'. 'A whole month before I conceived, he was telling people I had a baby in my belly,' Bright wrote. 'Maybe he already knows who this little soul is.' If you'd like to view this content, please adjust your . To find out more about how we use cookies, please see our Cookie Guide. Bright said younger son Halo has also connected with the baby. 'Every night, Halo falls asleep holding my belly — and every morning, he wakes up and kisses it,' she said. 'Our hearts are expanding, and so is our family. So deeply grateful for this growing love. #PregnancyMagic #IntuitiveKids.' Bright made headlines in 2021 when she uploaded a photo of her breastfeeding baby Flow while performing a handstand to celebrate her first Mother's Day. 'Becoming a mother has unleashed something inside of me,' she wrote in the caption. 'It's deeply spiritual. It's primal. It's raw. it's fierce. It is pure.' The post immediately went viral, prompting Bright to address the negative reaction in a video. Bright shared an Instagram story clarifying the post. Credit: Instagram She said it was 'just a little bit of pure fun' and 'celebrating the bond between mother and child'. She also said she could 'understand how it's not everyone's taste' but lamented the judgement. 'Mothers, we need to encourage each other,' she said in the Instagram video. 'We need to lift each other up. We need to pay each other compliments. 'We need to support each other. We need to be each other's biggest cheerleaders because motherhood is so beautiful, but the reality is we are the only ones who know just how hard those hard moments are. 'And we need to have each other's back. Not compare each other and judge each other, because we all do think so differently. That's why it's so beautiful.' She finished the video by asking: 'But did anyone really think that's how I breastfed?'

Son's intuition reveals Australian Olympic gold medallist Torah Bright's pregnancy
Son's intuition reveals Australian Olympic gold medallist Torah Bright's pregnancy

7NEWS

time3 hours ago

  • 7NEWS

Son's intuition reveals Australian Olympic gold medallist Torah Bright's pregnancy

Australian Winter Olympic gold medallist Torah Bright has announced she is pregnant with her third child. The 38-year-old former snowboarder has two sons with husband Angus Thomson — and she says it was their eldest who first revealed the latest addition. Bright said they are 'so excited' to become a family of five. 'The boys are hyped and so sweet with their baby growing in my belly!' she wrote. On Wednesday, Bright said they are not learning the gender until the baby arrives. 'But I'm feeling a third boy,' she said. The dual Olympic halfpipe medallist also shared that son Flow 'knew I was pregnant before I actually was'. 'A whole month before I conceived, he was telling people I had a baby in my belly,' Bright wrote. 'Maybe he already knows who this little soul is.' Bright said younger son Halo has also connected with the baby. 'Every night, Halo falls asleep holding my belly — and every morning, he wakes up and kisses it,' she said. 'Our hearts are expanding, and so is our family. So deeply grateful for this growing love. #PregnancyMagic #IntuitiveKids.' Bright made headlines in 2021 when she uploaded a photo of her breastfeeding baby Flow while performing a handstand to celebrate her first Mother's Day. 'Becoming a mother has unleashed something inside of me,' she wrote in the caption. 'It's deeply spiritual. It's primal. It's raw. it's fierce. It is pure.' The post immediately went viral, prompting Bright to address the negative reaction in a video. She said it was 'just a little bit of pure fun' and 'celebrating the bond between mother and child'. She also said she could 'understand how it's not everyone's taste' but lamented the judgement. 'Mothers, we need to encourage each other,' she said in the Instagram video. 'We need to lift each other up. We need to pay each other compliments. 'We need to support each other. We need to be each other's biggest cheerleaders because motherhood is so beautiful, but the reality is we are the only ones who know just how hard those hard moments are. 'And we need to have each other's back. Not compare each other and judge each other, because we all do think so differently. That's why it's so beautiful.' She finished the video by asking: 'But did anyone really think that's how I breastfed?'

First medicine for sleep apnoea approved for use by the TGA
First medicine for sleep apnoea approved for use by the TGA

9 News

time4 hours ago

  • 9 News

First medicine for sleep apnoea approved for use by the TGA

Your web browser is no longer supported. To improve your experience update it here The Therapeutic Goods Administration has approved the first medicine to treat sleep apnoea. Mounjaro, which has the active ingredient tirzepatide, is widely used to treat type 2 diabetes. However, the TGA has today expanded the drug's usage to include obstructive sleep apnoea for adults living with obesity. A medicine used to treat type 2 diabetes has now been approved for use in adults with obstructive sleep apnoea and obesity. (iStock) This makes Mounjaro the first and only medicine for obstructive sleep apnoea in Australia. The drug has not been listed on the Pharmaceutical Benefits Scheme and will only be available through private prescription. Mounjaro can now be used to treat moderate-to-severe obstructive sleep apnoea in adults living with a body mass index (BMI) of 30 or more. Mounjaro has been approved to treat sleep apnoea in adults living with obesity. (CNN) Mounjaro cannot be used to treat type 1 diabetes, or by children and teenagers under 18 years old. Side effects associated with Mounjaro can include an upset stomach, injection site-related side effects, and low blood sugar. Obstructive sleep apnoea is the most common of all sleeping disorders and is thought to affect around 780,000 Australian adults. It occurs when a person's upper airway becomes blocked, causing breathing to be repeatedly interrupted during sleep. Professor Brendon Yee is a respiratory and sleep physician at the Woolcock Institute of Medical Research who was involved in a clinical trial of Mounjaro for obstructive sleep apnoea. Yee said the TGA decision was a "long-awaited development" in the field of sleep medicine. "For the first time, people with weight-related obstructive sleep apnoea can be treated with a medicine that addresses the underlying cause of their condition," Yee said. "This marks a significant milestone in the treatment of this debilitating sleep disorder. "Obstructive sleep apnoea can affect anyone, and obesity is the single greatest cause of the condition. "At least 70 per cent of people living with obstructive sleep apnoea also live with obesity." health national medical medicine Sleep obesity CONTACT US

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store